Search research articles
Contact Us
Filters
Showing results (1-10 of 46) with videos related to
Page
of 5
Sort By:
Metabolic Engineering
|
July 17, 2004
Alternative pathways of galactose assimilation: could inverse metabolic engineering provide an alternative to galactosemic patients?
Kent Lai, Maria I Klapa
Gene Therapy
|
March 18, 2025
AAV-based gene replacement therapy prevents and halts manifestation of abnormal neurological phenotypes in a novel mouse model of PMM2-CDG
Mian-Ling Zhong, Kent Lai
Anticancer Research
|
December 7, 2016
The Leloir Pathway of Galactose Metabolism - A Novel Therapeutic Target for Hepatocellular Carcinoma
Manshu Tang, Enoabasi Etokidem, Kent Lai
Journal of Ovarian Research
|
November 22, 2022
Early postnatal alterations in follicular stress response and survival in a mouse model of Classic Galactosemia
Synneva Hagen-Lillevik, Joshua Johnson, Kent Lai
Future Medicinal Chemistry
|
July 29, 2014
GALK inhibitors for classic galactosemia
Kent Lai, Matthew B Boxer, Anna Marabotti
IUBMB Life
|
October 28, 2009
Galactose toxicity in animals
Kent Lai, Louis J Elsas, Klaas J Wierenga
Molecular Genetics and Metabolism
|
September 20, 2005
Intracellular galactose-1-phosphate accumulation leads to environmental stress response in yeast model
Tatiana Slepak, Manshu Tang, Freda Addo, et al.
Journal of Biomolecular Screening
|
May 21, 2008
High-throughput screening for human galactokinase inhibitors
Klaas J Wierenga, Kent Lai, Peter Buchwald, et al.
Molecular Genetics and Metabolism
|
July 24, 2007
Involvement of endoplasmic reticulum stress in a novel Classic Galactosemia model
Tatiana I Slepak, Manshu Tang, Vladlen Z Slepak, et al.
Tetrahedron
|
October 11, 2012
Formal Synthesis of 4-diphosphocytidyl-2-C-methyl D-erythritol From D-(+)-Arabitol
Sina I Odejinmi, Rafael G Rascon, Wyman Chen, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 46) with videos related to
Sort By:
Page
of 5
Metabolic Engineering
|
July 17, 2004
Alternative pathways of galactose assimilation: could inverse metabolic engineering provide an alternative to galactosemic patients?
Kent Lai, Maria I Klapa
Gene Therapy
|
March 18, 2025
AAV-based gene replacement therapy prevents and halts manifestation of abnormal neurological phenotypes in a novel mouse model of PMM2-CDG
Mian-Ling Zhong, Kent Lai
Anticancer Research
|
December 7, 2016
The Leloir Pathway of Galactose Metabolism - A Novel Therapeutic Target for Hepatocellular Carcinoma
Manshu Tang, Enoabasi Etokidem, Kent Lai
Journal of Ovarian Research
|
November 22, 2022
Early postnatal alterations in follicular stress response and survival in a mouse model of Classic Galactosemia
Synneva Hagen-Lillevik, Joshua Johnson, Kent Lai
Future Medicinal Chemistry
|
July 29, 2014
GALK inhibitors for classic galactosemia
Kent Lai, Matthew B Boxer, Anna Marabotti
IUBMB Life
|
October 28, 2009
Galactose toxicity in animals
Kent Lai, Louis J Elsas, Klaas J Wierenga
Molecular Genetics and Metabolism
|
September 20, 2005
Intracellular galactose-1-phosphate accumulation leads to environmental stress response in yeast model
Tatiana Slepak, Manshu Tang, Freda Addo, et al.
Journal of Biomolecular Screening
|
May 21, 2008
High-throughput screening for human galactokinase inhibitors
Klaas J Wierenga, Kent Lai, Peter Buchwald, et al.
Molecular Genetics and Metabolism
|
July 24, 2007
Involvement of endoplasmic reticulum stress in a novel Classic Galactosemia model
Tatiana I Slepak, Manshu Tang, Vladlen Z Slepak, et al.
Tetrahedron
|
October 11, 2012
Formal Synthesis of 4-diphosphocytidyl-2-C-methyl D-erythritol From D-(+)-Arabitol
Sina I Odejinmi, Rafael G Rascon, Wyman Chen, et al.
Page
of 5